Live and recent posts from across the Fediverse tagged #japanesepatients, aggregated by home.social.
Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer
First PMDA-approved molecular residual disease (MRD) test in Japan, supporting the use of Signatera in the adjuvant settin…
#Japan #JP #JapanNews #adjuvantchemotherapy #clinicalevidence #colorectalcancer #Japanese #Japaneseclinicians #Japanesenews #Japanesepatients #MedicalDevicesAgency #news #regulatoryapproval #Signatera
https://www.alojapan.com/1502757/signatera-receives-regulatory-approval-in-japan-for-colorectal-cancer/
https://www.alojapan.com/1502757/signatera-receives-regulatory-approval-in-japan-for-colorectal-cancer/ Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer #AdjuvantChemotherapy #ClinicalEvidence #ColorectalCancer #Japan #JapanNews #Japanese #JapaneseClinicians #JapaneseNews #JapanesePatients #MedicalDevicesAgency #news #RegulatoryApproval #Signatera First PMDA-approved molecular residual disease (MRD) test in Japan, supporting the use of Signatera in the adjuvant setting Commercial launch expected by year-end, pending final
https://www.europesays.com/dk/88745/ Semaglutide MASH Data Broadens Novo Nordisk Case For Undervalued Shares #JapanesePatients #LiverDisease #MASH #MenopausalWomen #NovoNordisk #SafetyProfile #SimplyWallSt #StockTrades
neffy® (epinephrine nasal spray) Approved in Japan as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
ARS Pharmaceuticals, Inc. nef…
#Japan #JP #JapanNews #allergicreactions #anaphylaxis #ARSPharma #emergencytreatment #epinephrine #Japanesepatients #nasalspray #neffy #news #pharmaceuticals
https://www.alojapan.com/1373297/neffy-epinephrine-nasal-spray-approved-in-japan-as-the-first-and-only-needle-free-emergency-treatment-of-allergic-reactions-anaphylaxis/
https://www.alojapan.com/1373297/neffy-epinephrine-nasal-spray-approved-in-japan-as-the-first-and-only-needle-free-emergency-treatment-of-allergic-reactions-anaphylaxis/ neffy® (epinephrine nasal spray) Approved in Japan as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis) #AllergicReactions #anaphylaxis #ARSPharma #EmergencyTreatment #epinephrine #Japan #JapanNews #JapanesePatients #NasalSpray #neffy #news #pharmaceuticals ARS Pharmaceuticals, Inc. neffy 1 mg and 2 mg doses approved by Japanese regulators neffy offers a new delivery method for epinephrine in Japan for adu
https://www.europesays.com/2405187/ Daughter sues Japan hospital for charging uninsured Chinese mother 300% more than locals #China #ChineseMother #Covid19Pandemic #japan #JapanesePatients #NationalCerebralAndCardiovascularCentre #Osaka #OsakaDistrictCourt #OsakaPrefecture #Suita #UNInternationalCovenantOnCivilAndPoliticalRights